Ursnon en es it fr

Ursnon Brand names, Ursnon Analogs

Ursnon Brand Names Mixture

  • L-S 100 Soluble Powder (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Sulfate))
  • Lincomycin Spectinomycin 100 Soluble Powder (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Hydrochloride))
  • Lincomycin Spectinomycin 4.4% G Premix (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Hydrochloride))

Ursnon Chemical_Formula


Ursnon RX_link


Ursnon fda sheet

Ursnon FDA

Ursnon msds (material safety sheet)

Ursnon MSDS

Ursnon Synthesis Reference

No information avaliable

Ursnon Molecular Weight

376.462 g/mol

Ursnon Melting Point

297 oC

Ursnon H2O Solubility

30 mg/L

Ursnon State


Ursnon LogP


Ursnon Dosage Forms

Drops; Suspension

Ursnon Indication

A topical anti-inflammatory product for ophthalmic use. For the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe

Ursnon Pharmacology

No information avaliable

Ursnon Absorption

No information avaliable

Ursnon side effects and Toxicity

Side effects may include acute anterior uveitis and perforation of the globe. Keratitis, conjunctivitis, corneal ulcers, mydriasis, conjunctival hyperemia, loss of accommodation and ptosis have occasionally been reported following local use of corticosteroids. LD50 = 234 mg/kg (rats)

Ursnon Patient Information

Ursnon Organisms Affected

Humans and other mammals